Ovarian Cancer
2,015
336
456
901
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
298 trials with published results (15%)
Research Maturity
901 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.7%
236 terminated out of 2015 trials
79.2%
-7.3% vs benchmark
8%
166 trials in Phase 3/4
33%
298 of 901 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 901 completed trials
Clinical Trials (2015)
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
A Study of Isoquercetin in People With Ovarian Cancer
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Cost Utility of Radical Surgery in Ovarian Cancer
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Trial of THEO-260 in Ovarian Cancer Patients